Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether hemodynamic optimization with photoplethysmography (ClearSight, Edwards Lifesciences, Irvine, CA) during colorectal surgery could decrease the incidence of perioperative complications.
All patients received the photoplethysmography monitoring, but the monitor was blinded in the control group.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group | No Intervention | Control group using a hemodynamic standard protocol | |
| Photoplethysmography group | Other | Hemodynamic optimization using Photoplethysmography device (ClearSight, Edwards Lifesciences, Irvine, CA) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Photoplethysmography | Device | Use Photoplethysmography for hemodynamic optimization during colorectal perioperative period |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of patients presenting at least one complication after colorectal surgery | Two independent experts defined the presence of complication using an a priori classification. | Up to 28 days after surgery (length of hospital stay) |
| Measure | Description | Time Frame |
|---|---|---|
| All complications happening after colorectal surgery | Up to 28 days after surgery (length of hospital stay) | |
| Real length of hospital stay | Up to 28 days after surgery (length of hospital stay) | |
| Measure | Description | Time Frame |
|---|---|---|
| Medico economic evaluation of cost of treatment | Medico economic evaluation of photoplethysmography use will be assessed with a specific unit of measure, using cost of treatment. | Up to 28 days after surgery (length of hospital stay) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anne-Lise Fiant, MD | University Hospital of Caen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Caen University Hospital | Caen | 14 000 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27004412 | Result | Fischer MO, Fiant AL, Boutros M, Flais F, Filipov T, Debroczi S, Pasqualini L, Rhanem T, Gerard JL, Guittet L, Hanouz JL, Alves A, Parienti JJ; PANEX3 study group. Perioperative hemodynamic optimization using the photoplethysmography in colorectal surgery (the PANEX3 trial): study protocol for a randomized controlled trial. Trials. 2016 Mar 22;17:159. doi: 10.1186/s13063-016-1278-4. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D003424 | Crohn Disease |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
| ID | Term |
|---|---|
| D017156 | Photoplethysmography |
| ID | Term |
|---|---|
| D010991 | Plethysmography |
| D003935 | Diagnostic Techniques, Cardiovascular |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Perioperative mortality |
| 28 days after surgery |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
| D015212 | Inflammatory Bowel Diseases |
| D005759 | Gastroenteritis |